1. Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.
- Author
-
Casasanta N, Kipnis ST, Linville L, Lipinski S, Knoedler A, Marino A, McHenry A, Biagi T, Stark E, Amdur R, Denduluri N, Rodriguez P, Isaacs C, and Kaltman R
- Subjects
- Adult, BRCA1 Protein genetics, BRCA2 Protein genetics, Breast pathology, Breast Neoplasms diagnosis, Breast Neoplasms pathology, Female, Gene Expression Profiling, Genetic Counseling, Germ-Line Mutation, Humans, Medical History Taking, Middle Aged, Neoplasm Recurrence, Local genetics, Neoplastic Syndromes, Hereditary genetics, Prognosis, Retrospective Studies, Breast Neoplasms genetics, Genetic Testing, Neoplasm Recurrence, Local epidemiology, Neoplastic Syndromes, Hereditary diagnosis
- Abstract
Background: Oncotype DX (ODX) is a genomic assay of tumor tissue that is utilized to predict the likelihood of recurrence and benefit of chemotherapy in breast cancer patients. Five to 10% of breast cancers are hereditary, and hereditary syndromes may not be uncovered through family history alone. We hypothesized that high ODX recurrence score (RS) may signal a potential hereditary cancer risk., Patients and Methods: We performed a retrospective analysis of data from hormone receptor-positive breast cancer patients who had undergone ODX and germline genetic testing. The chi-square test and Fisher exact test were used to examine univariable association between RS and germline mutation status. Multivariable logistic regression was utilized to examine if there was an association of RS with germline mutation status., Results: In univariable analysis, the association of RS with germline mutation status was significant (P < .0001). In the multivariable logistic regression model predicting germline mutation status, RS level remained significantly associated with germline mutation, in particular BRCA1 or BRCA2. The mean RS for those with non-BRCA1/2 germline mutations versus those without germline mutations was not significant (P = .38)., Conclusion: High RS is associated with germline mutation status. Breast cancer patients with high RS are more likely to harbor a mutation in the BRCA1 or BRCA2 genes. If confirmed prospectively, oncologists may consider referring patients with high RS for genetic risk assessment and counseling to inform management plans, as well as counseling of family members., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2020
- Full Text
- View/download PDF